Search Results

Modulation of inhibitory neurotransmission in brainstem vagal circuits by NPY and PYY is controlled by cAMP levels

Authors: browning, k. n.; travagli, r. a.

Source: Neurogastroenterology and Motility, Volume 21, Number 12, December 2009 , pp. 1309-e126(-1308)

Publisher: Blackwell Publishing

MDRNA has announced that its intranasal peptide YY 3-36 has failed to meet the primary and secondary endpoints of a phase II weight loss trial.

Source: Inpharma, Volume 1, Number 1650, 2008-08-09 , pp. 9-9(1)

Publisher: Adis International

Role of Islet-, Gut-, and Adipocyte-Derived Hormones in the Central Control of Food Intake and Body Weight: Implications for an Integrated Neurohormonal Approach to Obesity Pharmacotherapy

Authors: Chen, Hubert C.; Roth, Jonathan D.; Schroeder, Brock E.; Weyer, Christian

Source: Current Diabetes Reviews, Volume 4, Number 2, May 2008 , pp. 79-91(13)

Publisher: Bentham Science Publishers

Gut Hormones as Potential New Targets for Appetite Regulation and the Treatment of Obesity

Authors: Field, Benjamin C.T.; Wren, Alison M.; Cooke, Dunstan; Bloom, Stephen R.

Source: Drugs, Volume 68, Number 2, 2008 , pp. 147-163(17)

Publisher: Adis International

Relevance of the Neuropeptide Y System in the Biology of Cancer Progression

Authors: Ruscica, M.; Dozio, E.; Motta, M.; Magni, P.

Source: Current Topics in Medicinal Chemistry, Volume 7, Number 17, September 2007 , pp. 1682-1691(10)

Publisher: Bentham Science Publishers

Impact of Weight-Loss Medications on the Cardiovascular System: Focus on Current and Future Anti-Obesity Drugs

Authors: Drolet, Benoit; Simard, Chantale; Poirier, Paul

Source: American Journal of Cardiovascular Drugs, Volume 7, Number 4, 2007 , pp. 273-288(16)

Publisher: Adis International

Ghrelin and Other Gastrointestinal Peptides Involved in the Control of Food Intake

Authors: Tassone, F.; Broglio, F.; Gianotti, L.; Arvat, E.; Ghigo, E.; Maccario, M.

Source: Mini Reviews in Medicinal Chemistry, Volume 7, Number 1, January 2007 , pp. 47-53(7)

Publisher: Bentham Science Publishers

Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release and Actions

Author: Ballantyne, Garth

Source: Obesity Surgery, Volume 16, Number 5, May 2006 , pp. 651-658(8)

Publisher: Springer

Peptide YY(1-36) and Peptide YY(3-36): Part II. Changes after Gastrointestinal Surgery and Bariatric Surgery: Part I. Distribution, Release and Actions appeared in the last issue (May 2006)

Author: Ballantyne, Garth

Source: Obesity Surgery, Volume 16, Number 6, June 2006 , pp. 795-803(9)

Publisher: Springer

NIA0003

Authors: Le Roux, C; Batterham, R; Borg, C; Ghatei, M; Patel, A; Aylwin, S; Bloom, S

Source: Obesity Reviews, Volume 7, Supplement 2, September 2006 , pp. 37-37(1)

Publisher: Blackwell Publishing

Brain somatic cross-talk: Ghrelin, leptin and ultimate challengers of obesity

Authors: Popovic, Vera; Duntas, Leonidas H.

Source: Nutritional Neuroscience, Volume 8, Number 1, February, 2005 , pp. 1-5(5)

Publisher: Maney Publishing

The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity

Authors: Small, Caroline J; Bloom, Stephen R

Source: Expert Opinion on Investigational Drugs, Volume 14, Number 5, 1 May 2005 , pp. 647-653(7)

Publisher: Informa Healthcare

PYY3-36 as an anti-obesity drug target

Authors: Boggiano, M. M.; Chandler, P. C.; Oswald, K. D.; Rodgers, R. J.; Blundell, J. E.; Ishii, Y.; Beattie, A. H.; Holch, P.; Allison, D. B.; Schindler, M.; Arndt, K.; Rudolf, K.; Mark, M.; Schoelch, C.; Joost, H. G.; Klaus, S.; Thöne-Reineke, C.; Benoit, S. C.; Seeley, R. J.; Beck-Sickinger, A. G.; Koglin, N.; Raun, K.; Madsen, K.; Wulff, B. S.; Stidsen, C. E.; Birringer, M.; Kreuzer, O. J.; Deng, X. Y.; Whitcomb, D. C.; Halem, H.; Taylor, J.; Dong, J.; Datta, R.; Culler, M.; Ortmann, S.; Castañeda, T. R.; Tschöp, M.

Source: Obesity Reviews, Volume 6, Number 4, November 2005 , pp. 307-322(16)

Publisher: Blackwell Publishing

Peptide YY: A Potential Therapy for Obesity

Authors: D. Renshaw; R. L. Batterham

Source: Current Drug Targets, Volume 6, Number 2, March 2005 , pp. 171-179(9)

Publisher: Bentham Science Publishers

The Hypothalamus and Obesity

Author: Peter J. King

Source: Current Drug Targets, Volume 6, Number 2, March 2005 , pp. 225-240(16)

Publisher: Bentham Science Publishers

Abnormality of Peptide YY and Pancreatic Polypeptide Immunoreactive Cells in Colonic Mucosa of Patients with Colonic Inertia

Authors: Zhao, Rong; Baig, Khurrum; Wexner, Steven; Woodhouse, Sherry; Singh, Jay; Weiss, Eric; Nogueras, Juan

Source: Digestive Diseases and Sciences, Volume 49, Numbers 11-12, November 2004 , pp. 1786-1790(5)

Publisher: Springer

Gut Hormones as Peripheral Anti Obesity Targets

Authors: Caroline J. Small; Stephen R. Bloom

Source: Current Drug Targets-CNS & Neurological Disorders, Volume 3, Number 5, October 2004 , pp. 379-388(10)

Publisher: Bentham Science Publishers

The appetite-regulating peptide YY 3-36 (PYY3-36) nasal spray may reduce intake of calories and facilitate weight loss

Source: Inpharma, Volume 1, Number 1445, 2004-07-10 , pp. 10-10(1)

Publisher: Adis International

Clinical Evaluation of Anti-Obesity Drugs

Author: Wilding J.

Source: Current Drug Targets, Volume 5, Number 3, April 2004 , pp. 325-332(8)

Publisher: Bentham Science Publishers

Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [³⁵S]GTPS binding

Authors: Shaw J.L.; Gackenheimer S.L.; Gehlert D.R.

Source: Journal of Chemical Neuroanatomy, Volume 26, Number 3, November 2003 , pp. 179-193(15)

Publisher: Elsevier